Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
W Liang, W Guan, R Chen, W Wang, J Li, K Xu… - The lancet …, 2020 - thelancet.com
China and the rest of the world are experiencing an outbreak of a novel betacoronavirus
known as severe acute respiratory syndrome corona virus 2 (SARS-CoV-2). 1 By Feb 12 …
known as severe acute respiratory syndrome corona virus 2 (SARS-CoV-2). 1 By Feb 12 …
Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis
Pancreatic cancer is a malignancy with poor prognosis and high mortality. The recent
increase in pancreatic cancer incidence and mortality has resulted in an increased number …
increase in pancreatic cancer incidence and mortality has resulted in an increased number …
[HTML][HTML] Worldwide burden of, risk factors for, and trends in pancreatic cancer
Background & Aims We evaluated global and regional burdens of, risk factors for, and
epidemiologic trends in pancreatic cancer among groups of different sexes and ages …
epidemiologic trends in pancreatic cancer among groups of different sexes and ages …
Updated epidemiology of gastrointestinal cancers in East Asia
Globally, gastrointestinal cancers represent more than one-fourth of all cancer incidence
and one-third of cancer-related mortality. Although there has been much progress in …
and one-third of cancer-related mortality. Although there has been much progress in …
Overall survival results from the POLO trial: a phase III study of active maintenance olaparib versus placebo for germline BRCA-mutated metastatic pancreatic cancer
PURPOSE The phase III POLO study demonstrated significant progression-free survival
(PFS) benefit for active olaparib maintenance therapy versus placebo for patients with …
(PFS) benefit for active olaparib maintenance therapy versus placebo for patients with …
[HTML][HTML] Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study
N Nagata, S Nishijima, Y Kojima, Y Hisada, K Imbe… - Gastroenterology, 2022 - Elsevier
Background & Aims To identify gut and oral metagenomic signatures that accurately predict
pancreatic ductal carcinoma (PDAC) and to validate these signatures in independent …
pancreatic ductal carcinoma (PDAC) and to validate these signatures in independent …
[HTML][HTML] Injectable self-healing adhesive pH-responsive hydrogels accelerate gastric hemostasis and wound healing
Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are
well-established therapeutics for gastrointestinal neoplasias, but complications after …
well-established therapeutics for gastrointestinal neoplasias, but complications after …
[HTML][HTML] European cancer mortality predictions for the year 2021 with focus on pancreatic and female lung cancer
Background We predicted cancer mortality statistics for 2021 for the European Union (EU)
and its five most populous countries plus the UK. We also focused on pancreatic cancer and …
and its five most populous countries plus the UK. We also focused on pancreatic cancer and …
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
T Conroy, P Pfeiffer, V Vilgrain, A Lamarca… - Annals of …, 2023 - annalsofoncology.org
The opportunity to detect pancreatic cancer (PC) when potentially curable depends on early
diagnosis and an ability to identify and screen high-risk populations before symptoms arise …
diagnosis and an ability to identify and screen high-risk populations before symptoms arise …
[HTML][HTML] Pancreatic cancer in 2021: What you need to know to win
V Tonini, M Zanni - World Journal of Gastroenterology, 2021 - ncbi.nlm.nih.gov
Pancreatic cancer is one of the solid tumors with the worst prognosis. Five-year survival rate
is less than 10%. Surgical resection is the only potentially curative treatment, but the tumor is …
is less than 10%. Surgical resection is the only potentially curative treatment, but the tumor is …